However, before we could apply memory T cells as a biomarker, numerous critical questions remain to be answered, including the development of tissue-resident memory T-cell subsets, the possible differences between CD4+ and CD8+ memory T-cell subsets, and finally the role of persistent parasite in TRM survival in human leishmaniasis. This evidence concerns the gene CD4 and leishmaniasis.